1 Followers
3 Following
ahila

ahila

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Patient Tracking Systems Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2024

Global Patient Tracking Systems Market:By Type (Integrated, Standalone), By Product (Real Time Locating Systems (RLTS), Event Driven Solutions), By Mode of the Delivery (Cloud based, Web based, On-premise), By Components (Software, Hardware, Services), By End User (Ambulatory Surgical Centers, Hospitals, Clinics), and Geography -Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis2012 to 2016 and Forecast 2017 to 2024

 

Patient Tracking Systems Market: Market Dynamics

 

Patient tracking system is a key component of analyzing the patient flow and patient security solution. Patient tracking system ensures healthcare staff and security personnel to locate the patient quickly hospital wide and allows hospitals to admit more patients efficiently, after a patient is discharged the tracking tag will be removed and place in a drop box to notify housekeeping or any other healthcare staff or professionals automatically. High return on investment by adopting the patient tracking systems, rise in demand for the improved advancements in management of patient care and focus, favorable incentives by the government propels the growth of the patient tracking system market globally.  Furthermore, enhanced productivity from the staff, ease in managing the patients, cost reduction in maintenance are the other factors that drives the growth of patient tracking systems market globally. However, huge investment on the implementation and installation of the systems, dearth of the skilled professionals, concerns regarding the patient confidentiality may hamper the growth of the patient tracking systems market globally.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-patient-tracking-systems-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Patient Tracking Systems Market

Patient Tracking Systems Market is segmented on the basis of type, product, and component, mode of delivery, End user and Geographical regions

Based on the Type, Patient Tracking Systems Market is segmented into the following:

  • Integrated
  • Standalone

Based on the Product,Patient Tracking Systems Market is segmented into the following:

  • Real Time Locating Systems (RLTS)
  • Event Driven Solutions

Based on the Mode of the Delivery, Patient Tracking Systems Market is segmented into the following:

  • Cloud based
  • Web based
  • On premise

Based on the Components, Patient Tracking Systems Market is segmented into the following:

  • Software
  • Hardware
  • Services

Based on the End User, Patient Tracking Systems Marketis segmented into the following:

  • Ambulatory Surgical Centers
  • Hospitals
  • Clinics

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-patient-tracking-systems-market/#ulp-c654SbFYO64MsOhu

 

 

Regional Analysis:  Patient Tracking Systems Market

Geographically, Patient Tracking Systems Marketis segmented into North America, Europe, Asia Pacific, Latin America, and theMiddle East and Africa regions. North America accounts largest market for Patient Tracking Systems followed by Europe, owing to the advancements in technologies, increase emphasis on improving patient flow, rise in focus on reducing healthcare expenditure. Asia Pacific region and Latin America region is anticipated to show lucrative growth due to rise in demand for healthcare services, growing investments on patient care, growing awareness regarding technology. MEA is also expected to show significant growth in patient tracking systems market owing to the rise in healthcare standards of the counties in MEA region.

 

Competition Assessment: Patient Tracking Systems Market

Key playersprofiled in the global Patient Tracking Systems Marketinclude:

  • Awarepoint Corporation (U.S.)
  • Allscripts Healthcare Solutions, Inc. (U.S.)
  • Central Logic, Inc. (U.S.)
  • Care Logistics, LLC (U.S.)
  • Intelligent InSites, Inc. (U.S.)
  • Cerner Corporation (U.S.)
  • Medworxx Solutions, Inc. (Canada)
  • McKesson Corporation (U.S.)
  • Sonitor Technologies, Inc. (U.S.)
  • STANLEY Healthcare (U.S.)
  • Epic Systems Corporation (U.S.)
  • TeleTracking Technologies, Inc. (U.S.)

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-patient-tracking-systems-market/#ulp-14mlyhjMGhVjZqa3

 

Key Features of the Report:

  • The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key marketdevelopments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Get access to full summary @

 

https://www.precisionbusinessinsights.com/market-reports/global-patient-tracking-systems-market/

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

Source: http://www.precisionbusinessinsights.com/market-reports/global-patient-tracking-systems-market

Global Patient Monitoring Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Patient monitoring devices are the devices with the digital technology used to measure the person’s health condition. The accuracy of the results with patient monitoring devices may help to early diagnosis of the disease, leads to more efficient and specific treatment. The major advantages of the patient monitoring devices include accuracy of the results with less time and reduce the cost for disease diagnosis. These devices are commonly used to measure oxygen saturation level, pulse rate, body temperature, blood pressure, and heart activity among others. Physicians prefer the patient monitoring devices to enhance the excellence in the patient care.

 

 

Increase in the technological advancements such as wireless devices of patient monitoring devices, the rise in prevalence of various diseases such as diabetes and hypertension which require lifelong monitoring, increase in geriatric population, growth in the adoption of patient monitoring devices are anticipated to fuel the growth of patient monitoring devices. Moreover, increase in the healthcare awareness, ease of operating and availability of the wider products in the market, and rise in healthcare expenditure expected to propel the market Global Patient Monitoring Devices Market over the forecast period. However, product recalls, lack of awareness in rural areas, a high cost of the devices, and lack of favorable reimbursement policies for medical devices are the key factors restrain the patient monitoring devices market growth.

 

         

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-patient-monitoring-devices-market/#ulp-4H8Z4LpNMLEuOnnx

 

Patient monitoring devices market is segmented on the basis of product type, technology, application, and end user

 

Based on the product type, patient monitoring devices are segmented into the following:

  • Blood pressure monitors
  • Blood glucose monitors
  • Heart rate monitors
  • Pulse oximeters
  • Weight monitors
  • Sleep apnoea monitors
  • Breath monitors
  • Others

 

Based on the technology, patient monitoring devices are segmented into the following:

  • Portable devices
  • Standalone devices
  • Wireless technology devices
  • Others

 

Based on the application, patient monitoring devices are segmented into the following:

  • Cardiovascular conditions
  • Neurological conditions
  • Haematological conditions
  • Respiratory conditions
  • Physiological conditions
  • Others

 

Based on the end user, patient monitoring devices are segmented into the following:

  • Hospitals
  • Clinics
  • Ambulatory surgical centres
  • Home care settings
  • Others

 

     To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-patient-monitoring-devices-market/#ulp-c654SbFYO64MsOhu

 

Patient monitoring devices market is growing at a significant CAGR owing to increase in the prevalence of chronic diseases such as diabetes, cardiovascular, and neurological advancements. Market players majorly focusing on the innovation of new devices with advanced technology to gain larger market share. Acquisitions and mergers, collaborations, product approvals, product launchings, and patent approvals are the strategies followed by the competitors for increasing their revenue in the patient monitoring devices market. For instance, in September 2015, Zoll Medical Corporation acquired Kyma Medica Technology for broadening the product portfolio in cardiovascular monitoring devices. In addition, in March 2014, Nihon Kohden has awarded a U.S. patent for the advanced technology which reduces the false alarms in the patient monitoring systems.

 

 

Geographically, patient care monitoring devices are segmented into Europe, North America, Latin America, Asia Pacific, and Middle East and Africa. North America holds significant share in patient monitoring devices owing to rise in geriatric population prone to chronic diseases such as diabetes and cancer, increase in healthcare expenditure, and patent approvals for novel technologies in the region. In Europe, due to high adoption of novel technologies, technological advancements, and well-developed healthcare infrastructure are propelling the patient monitoring devices market. However, Asia Pacific exhibiting significant growth in global market which is attributed to growing prevalence of chronic diseases, rise in healthcare expenditure, and rise in per capita income are driving the patient monitoring devices market in the region.

 

 Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-patient-monitoring-devices-market/#ulp-14mlyhjMGhVjZqa3

 

 

Some of the players in patient monitoring devices market are GE Healthcare (U.K.), Philips Healthcare (Netherlands), Nihon Kohden (Japan), Roche Diagnostics Limited (Switzerland), Abbott Laboratories (U.S), Omron Healthcare (Japan), Zoll Medical Corporation (U.S.), Cardinal Health (U.S.), and Medtronic (Ireland) to name a few.

 

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-patient-monitoring-devices-market/

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised which follow a holistic approach to solve needs of market research services based on our client needs.

 

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

 

Source: http://www.precisionbusinessinsights.com/market-reports/global-patient-monitoring-devices-market

Global Parkinson’s Treatment Market : Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2024

 

Global Parkinson’s Treatment Market :Parkinson’s disease is the chronic, progressive neurodegenerative disorder that is characterized by rigidity, tremors, postural instability and bradykinesia (slowness of movement) and patients will also experience the significant non-motor symptoms like changes in the sleep disturbances, autonomic dysfunction and cognition and mood. The condition is caused due to the degeneration of the dopamine-producing cells of substantia nigra. Parkinson’s disease is non-fatal but it cannot be cured, that results in the poor quality of life and increases disability along with the disease progression. As per the World Health Organization, the total number of people with disability-adjusted life year because of Parkinson’s disease was 1.7 Mn globally in 2015.

 

Recent advancements in the treatment of  Parkinson’s disease like combination or multiple  therapies in order to prolong the actions of the continuous stimulation of dopaminergic drugs, neurostimulation devices approvals, neuroprotective therapies which slows the prognosis of Parkinson’s disease are anticipated to drive Parkinson’s disease treatment market globally.Furthermore, increase in aging of the population, rise in the Parkinsonism prevalence around the globe, treatment affordability are the factors bolstering the demand for some of the Parkinson’s disease treatment market. Factors such as loss of patent protection for some of the drugs, rise in competition from generic drugs of Parkinsonism, huge unmet needs in the market, delaying development and launch of new products in market are the few restraints for the Parkinson’s disease treatment market growth. High competition in market from other improved Parkinson’s disease management methods also hinders the growth of the Parkinson’s treatment market.

 

     A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-parkinsons-treatment-market/#ulp-4H8Z4LpNMLEuOnnx 

 

The global Parkinson’s treatment market has been classified on the basis of treatment, end user, and geography.

 

Based on drug class, global Parkinson’s treatment market is segmented into the following:

  • Monoamine Oxidase Inhibitors (MAO)
  • Dopamine Precursors
  • Catechol-o-methyltransferase Inhibitors (COMT)
  • Peripheral Decarboxylase Inhibitors
  • Others (Anticholinergics, Antihistaminics)

 

Based on distribution channel, global Parkinson’s treatment market segmented as:

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Drug Stores

 

  To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-parkinsons-treatment-market/#ulp-c654SbFYO64MsOhu 

 

Parkinson’s disease is predominantly treated by mature and long-standing therapies like dopamine agonists and levodopa, hence, generic medicines are dominating the market. Adipose-derived stem cell therapy, Repetitive transcranial magnetic stimulation device, and minimally invasive neurostimulation devices, among others are the new advancements in the Parkinson’s treatment. Healthcare professionals are adopting to the advancements in technologies that will offer better treatment quality when compared to conventional treatment and devices like stereotactic systems and ultrasonic aspirators. Drug manufacturers are introducing novel options for the treatment with clear defined position in market, specifically as option in reduction of motor fluctuations alongside levodopa therapy. Acquisitions, new product launches and Collaboration agreements are few strategies which were adopted by key players. For instance, in 2015 January, Neuropore Therapies Inc. entered into a commercialization agreement with UCB S.A, for commercialization of NPT200-11, a small molecule drug useful to treat the Parkinson’s disease.

 

   To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-parkinsons-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically, the global Parkinson’s disease treatment market is segmented into five regions namely, Latin America, North America, Asia-Pacific, Europe, and Middle East and Africa. North America dominates the global market for Parkinson’s disease treatment owing to the good reimbursement policies and high prevalence of the disease. As per the Parkinson’s disease Foundation, approximately every year 60,000 Americans were diagnosed with Parkinson’s disease. Europe is anticipated to hold the 2nd highest market share in the global market due to the increase in R&D investments by major players, growing disability-adjusted life years is driving the growth of the European Parkinson’s Treatment Market. As per the European Parkinson’s Disease Association, the disease treatment cost in Europe was estimated at US$ 12.6 Mn in 2015 and is expected to double by 2030. Rising prevalence of the disease and increasing demand for new drug therapies are the key drivers of the market. About 6.3 million people suffer from Parkinson’s disease according to the European Brain Council.

 

Some of the players in global Parkinson’s disease treatment market include Salix Pharmaceuticals (U.S.), GlaxoSmithKline Plc. (U.K.), Wockhardt Limited (India), Impax Laboratories, Inc. (U.S), Novartis AG (Switzerland), Mylan N.V (U.S), Teva Pharmaceutical Industries Ltd.(Israel), Cipla Inc.(India), Par Pharmaceutical (U.S), and Apotex Inc (Canada)

 

 

 

 

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-parkinsons-treatment-market/

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

 

 

 

 

Source: http://www.precisionbusinessinsights.com/market-reports/global-parkinsons-treatment-market

Global Pancreatic Cancer Therapeutics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Pancreatic cancer is the disease characterized by the abnormal proliferation of tumor cells in the pancreas leads to hinder in the pancreas function. Pancreatic cancer is majorly classified into 2 types namely exocrine cancers and neuroendocrine cancers. Symptoms associated with the pancreas cancer include jaundice, weight loss, abdominal pain, and diarrhea. Pancreatic cancer mainly occurs due to the consumption of tobacco and alcohol, smoking, obesity, and family history of pancreatitis. Pancreatic cancer can be diagnosed by using the MRI, CT scan, and ultrasound techniques and can be prevented by chemotherapy, radiotherapy, and surgery.

 

Increase in the alcohol and tobacco consumption, a rise in the government funding for the R&D activities, growing prevalence of pancreatic cancer diseases, and promising pipeline drugs for the pancreatic cancer treatment are anticipated to propel the pancreatic cancers market growth over the forecast period. Furthermore, rise in obesity population, family history of pancreatitis, huge investment by the companies for the development of newer drugs expected to drive the Global Pancreatic Cancer Therapeutics Market over the forecast period. However, stringent regulatory policies, difficulty in early-stage disease diagnosis, the high cost of the treatment, adverse effects associated with the drugs, and lesser drugs available for the treatment might hamper the growth of Global Pancreatic Cancer Therapeutics Market.

 

          A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-pancreatic-cancer-therapeutics-market/#ulp-4H8Z4LpNMLEuOnnx

 

Pancreatic cancer therapeutics market is segmented on the basis of disease type, treatment type, and end user

 

Based on the treatment type, pancreatic cancer therapeutics market is segmented into the following:

  • Chemotherapy
    • Alkylating agents
    • Anti-metabolites
    • Natural products
    • Others
  • Targeted therapy
  • Others

 

Based on the disease type, pancreatic cancer therapeutics market is segmented into the following:

  • Exocrine pancreas cancer
  • Exocrine pancreas cancer

 

Based on the distribution channel, pancreatic cancer therapeutics market is segmented into the following:

  • Hospital pharmacies
  • Retail Pharmacies
  • Online pharmacies

 

     To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-pancreatic-cancer-therapeutics-market/#ulp-c654SbFYO64MsOhu

 

 

Pancreatic surgery therapeutics market is growing at a significant CAGR owing to increase in the prevalence of the pancreatic cancer and increase in R&D activities for the innovation of newer therapeutics. Increase in the government funding and huge investments from private sector for R&D activities is anticipated to propel the market growth. Acquisitions & mergers, collaborations, product pipeline are the key factors driving the market players revenue growth in pancreatic cancer therapeutics market. For instance, in December 2015, Boehringer Ingelheim collaborated with MD Andersen Cancer Centre for the development of newer therapeutics for pancreatic cancer. Similarly, in September 2013, Celgene received FDA approval for Abraxane used for the treatment of pancreatic cancer.

 

  Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-pancreatic-cancer-therapeutics-market/#ulp-14mlyhjMGhVjZqa3 

 

 

Geographically, pancreatic cancer therapeutics market is segmented into the Europe, Latin America, Asia Pacific, Middle East and Africa, and North America. North America pancreatic cancer therapeutics market is growing at significant rate due to increase in the prevalence of pancreatic cancer majorly in U.S. (according to NIH 2014, about 64,668 people diagnosed with pancreatic cancer). In addition, high adoption of pancreatic therapeutics, increase in healthcare expenditure, and rise in R&D activities are propelling the pancreatic cancer therapeutics market in North America. In Europe region, rise in the prevalence of pancreatic cancer majorly in Germany, Finland, Austria, U.K and other Europe countries (according to Cancer Research UK 2014, about 9,600 new pancreatic cancer cases in UK and 8,817 people died of the disease), and developed healthcare infrastructure boost the pancreatic cancer therapeutics market. However, Asia Pacific is an emerging region for pancreatic cancer therapeutics market owing to increase in R&D expenditure rise in geriatric and obese population, growing healthcare expenditure are expected to fuel the market over the forecast period.

 

 

Some of the players in pancreatic cancer therapeutics market are F. Hoffmann-La Roche Ltd. (Switzerland), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), Pfizer, Inc. (U.S.), Eli Lilly and Company (U.S.), Boehringer Ingelheim GmbH (Germany), Celgene Corporation (U.S.), Amgen, Inc. (U.S.), Tempus, Inc. (U.S.), and Ipsen (France) to name a few.

 

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-pancreatic-cancer-therapeutics-market/

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised which follow a holistic approach to solve needs of market research services based on our client needs.

 

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

 

 

Source: http://www.precisionbusinessinsights.com/market-reports/global-pancreatic-cancer-therapeutics-market

Pancreatic Cancer Diagnostics Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Market Outline: Pancreatic Cancer Diagnostics Market

Pancreatic cancer will begin in tissues of pancreas. Pancreas secretes enzymes which helps in the digestion and manage blood sugar levels. Pancreatic cancer rapidly spreads to the nearby organs. Often it can be diagnosed at early stages in people with pancreatic cyst or family history of pancreatic cancer. Most common sign of pancreatic cancer is diabetes which occurs along with loss of weight, pain in the upper abdomen and that spreads to the back.

Market Dynamics: Pancreatic Cancer Diagnostics Market

Increasing prevalence of pancreatic cancer is expected to accelerate the growth of pancreatic cancer diagnostics market. According World Cancer Research Fund International, pancreatic cancer is the 12th most common cancer, and it has estimated that about 3, 38,000 cases were diagnosed with pancreatic cancer in 2012. Moreover, Growing awareness and concern about the disease, increase in healthcare expenditure, technological advancements and innovation of new products, large number of unmet needs related to disease are the few factors which are expected to fuel the growth of pancreatic cancer diagnostics market. However, limited options for treatment, inaccurate and inadequate results of the diagnosis, high cost associated with the tests are major restraints of pancreatic cancer diagnostics market.

 

  A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-pancreatic-cancer-diagnostics-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Market Scope: Pancreatic Cancer Diagnostics Market

Global pancreatic cancer diagnostics market is classified on the basis of type of test, type of cancer, end user, and geography.

Based on type of test, global pancreatic cancer diagnostics market is segmented into

  • Blood Tests
  • Biopsy
  • Biological Markers

Based on type of cancer, global pancreatic cancer diagnostics market is segmented into

  • Adenocarcinoma
  • Squamous carcinoma
  • Adenosquamous carcinoma

Based on end user, global pancreatic cancer diagnostics market is segmented into

  • Hospitals
  • Oncology Institutes
  • Diagnostic Centres

 

 To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-pancreatic-cancer-diagnostics-market/#ulp-c654SbFYO64MsOhu

 

 

Market overview: Pancreatic Cancer Diagnostics Market

Technologies for timely diagnosis of pancreatic cancer are yet to develop at a full stretch which may results in early diagnosis of advanced stage of pancreatic cancer and can provide rightful treatment. Moreover, major players are getting collaborated with government and other social responsible agencies to improve the patient accessibility and affordability towards the treatments and diagnosis. For example, Illumina, Inc. has launched a venture called GRAIL along with Billgates and Jeff Bezos as investors with $100 Mn to focus on the blood based cancer screening for early and timely diagnosis of the common tumours through simple laboratory tests

Region Overview: Pancreatic Cancer Diagnostics Market

Geographically global pancreatic cancer diagnostics market is segmented into Latin America, Europe, Asia-Pacific, North America, and the Middle East & Africa. North America is dominating the pancreatic cancer diagnostics market globally owing to increase in technological advancements associated with pancreatic cancer treatment methods and increase in prevalence and incidence of pancreatic cancer. According to American cancer society, in 2017, it is estimated that around 54,000 people are diagnosed and 43,000 people are going to die because of pancreatic cancer in US. Europe holds the second largest position in pancreatic cancer diagnostics market owing to the advanced technologies and rapid prevalence of pancreatic cancer In 2014, according to Cancer Research UK, it was reported that around 10,000 cases diagnosed with pancreatic cancer. The Asia-Pacific region is anticipated to show significant growth during the forecast period due to high prevalence of pancreatic cancer, presence of large unmet needs, growing emerging economies like India and China.

 

   Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-pancreatic-cancer-diagnostics-market/#ulp-14mlyhjMGhVjZqa3

 

 

 

Competition Assessment: Pancreatic Cancer Diagnostics Market

Some of the key player for global pancreatic cancer diagnostics market includes Ambry Genetics (U.S), Abbott Laboratories, Inc. (U.S), AstraZeneca plc. (U.K), Eli Lilly and Company(U.S.), bioMeriux SA (France), Illumina, Inc.(U.S), Genoptix, Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Pfizer, Inc. (U.S.),GlaxoSmithKline plc (UK), Amgen, Inc.(U.S), Celgene corporation (U.S), and Novartis AG (Switzerland).

Market Developments: Pancreatic Cancer Diagnostics Market

  • In October 2015, Immunovia AB and the Knight Cancer Institute at Orgeon Health & Science University (OHSU) formed a collaboration to confirm and validate and commercialize the IMMray PanCan-d to early diagnosis of pancreatic cancer.
  • In August 2016, Interpace Diagnosis Group launched new version of AccuCEA product called “Insights” to test pancreatic cancer.

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2012 to 2016) and forecast (2017 to 2023)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

 

Get access to full summary @

 

https://www.precisionbusinessinsights.com/market-reports/global-pancreatic-cancer-diagnostics-market/

 

 About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

 

 

Source: http://www.precisionbusinessinsights.com/market-reports/global-pancreatic-cancer-diagnostics-market

Global Ovarian Cancer Treatment Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Ovarian cancer is a type of cancer, which affects ovaries it causes rapid and abnormal increase of cell growth in ovaries. The exact cause of cancer is still unknown. An epithelial tumour, germ cell tumour and primary peritoneal carcinoma are types of ovarian cancer. Common symptoms include pressure in pelvis or lower back, changes in bowel movements, tiredness or low energy and more frequent urination. In most of the ovarian cancer cases, cancer will not be diagnosed until it has progressed to an advanced stage. Ovarian cancer is one of most common cause of cancer deaths in woman. Thereby need for development of the more effective drugs in treatment of ovarian cancer.

 

Increase in incidence of ovarian cancer worldwide is driving the ovarian cancer treatment market. According to WHO, an estimated 238,700 woman are diagnosed with ovarian cancer in 2012. The increase in older woman population, rising government funding and raising health care awareness able to grow ovarian cancer treatment market over the forecast period. According to ovarian cancer research fund alliance, the rate of prevalence of ovarian cancer is higher in woman between 55 to 66 years, many of the cancer foundations are funding to educate patients and healthcare professionals regarding symptoms and treatment options for ovarian cancer which may impact ovarian cancer market revenue growth positively over a forecast period. However, availability of generic drugs, lack of accurate diagnosis of ovarian cancer, and patient expiry of the key patented drugs like gemzar, taxol and paraplatin are expected to hamper the ovarian cancer treatment market.

 

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-ovarian-cancer-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Ovarian cancer treatment market segmented on the basis of type of cancer, drug class, and stage

 

Based on type of cancer, ovarian cancer treatment market is segmented into

  • Epithelial Ovarian Tumor
  • Ovarian Germ Cell Tumor
  • Ovarian Stomatal Tumor
  • Primary Peritoneal Carcinoma

 

Based on drug class, ovarian cancer treatment market is segmented into

  • Chemotherapeutic Agents
  • Targeted Therapy Drugs
  • Immune System Modulators
  • Hormones

 

Based on distribution channel, ovarian cancer treatment market is segmented into

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-ovarian-cancer-treatment-market/#ulp-c654SbFYO64MsOhu

 

 

Companies operating in ovarian cancer market investing in developing new drug therapies and finding newer molecular targets to treat ovarian cancer. For instance, Vintafolide an investigational targeted cancer therapeutic currently under development by Endocyte and Merck & Co. and faltetuzumab a monoclonal antibody being investigated for the treatment of ovarian cancer this was developed by Morphotek, Inc. The introduction of new drug therapies like gene therapy, radiation therapy and targeted drug therapy are projected to improve ovarian cancer market revenue growth over forecast period. Global ovarian cancer market currently dominated by generic drugs and development of more effective drugs is challenging for market players. Some of the new drugs like avastin, lynparza and yondelis are approved in recent years to treat cancer and these drugs are slowly capturing market share.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-ovarian-cancer-treatment-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically ovarian cancer treatment market has been segmented into following regions viz. North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. North America dominates the ovarian cancer treatment market due to rising number of ageing population. According to American cancer society, in U.S. about 22,440 women will receive a new diagnosis of ovarian cancer and about 14,080 women will die from ovarian cancer in 2017. Europe is largest market as the incidence rates of ovarian cancer is increased in the region.

 

Some of the players in ovarian cancer treatment market include Eli Lilly and Company (U.S.), Johnson & Johnson Services, Inc. (U.S.), Novogen Limited (Australia) , Aeterna Zentaris Inc. (U.S)., GlaxoSmithKline plc (UK), Boehringer Ingelheim GmbH (Germany) and F. Hoffmann-La Roche AG (Switzerland) to name a few.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-ovarian-cancer-treatment-market/

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

 

Source: http://www.precisionbusinessinsights.com/market-reports/global-ovarian-cancer-treatment-market

Global Ovarian Cancer Diagnostics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

Ovarian Cancer Diagnostics is the disease characterized by the abnormal growth of cells in the ovarian tissue. Ovarian Cancer Diagnostics Market is the most common type of cancer in the women. Types of ovarian cancer include a stromal tumour, germ cell tumour, and epithelial tumours. Symptoms associated with ovarian cancer include abdominal pressure, swelling, loss of appetite, urinary urgency, low back pain, and pelvic discomfort among others. Ovarian cancer can be diagnosed by MRI, CT, PET scans, blood tests, ultrasound, and pelvic examination.

 

 

Increase in the ageing women population, rise in technological advancements for disease diagnosis, increase in the prevalence of ovarian cancer around the globe, and rise in healthcare awareness among key stakeholders are anticipated to bolster the ovarian cancer diagnostics market. Furthermore, highly developed healthcare infrastructure in developed countries, a rise in income per capita, and government initiative programs for increasing awareness about the ovarian cancer are expected to boost the ovarian cancer market growth over the forecast period. However, a high cost of the diagnostic procedure, lack of accuracy in disease diagnosis, stringent regulatory policies for diagnostic device approvals, and lack of early diagnostic tests and early warning systems might hamper the ovarian cancer diagnostics market over the forecast timeframe.

 

          A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-ovarian-cancer-diagnostics-market/#ulp-4H8Z4LpNMLEuOnnx

 

Ovarian cancer diagnostics market is segmented on the basis of diagnosis type, disease type, and end user

 

Based on the diagnosis type, ovarian cancer diagnostics market is segmented into the following:

  • Biopsy
  • MRI scan
  • CT scan
  • PET scan
  • Ultrasound
  • Blood test
  • Others

 

Based on the disease type, ovarian cancer diagnostics market is segmented into the following:

  • Stromal tumour
  • Germ cell tumour
  • Epithelial tumour
  • Primary peritoneal carcinoma

 

Based on the end user, ovarian cancer diagnostics market is segmented into the following:

  • Hospitals
  • Clinics
  • Diagnostic centres
  • Others

 

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-ovarian-cancer-diagnostics-market/#ulp-c654SbFYO64MsOhu

 

 

 

Ovarian cancer diagnostics market is growing at a significant CAGR owing to increase in the prevalence of ovarian cancer around the globe. According to World Cancer Research Fund International, about 239,000 new cases were diagnosed in 2012. Acquisitions and mergers, collaborations, innovation of novel diagnostic procedures are key strategies followed by the companies for increasing their revenue. For instance, In January 2015, VolitionRx Ltd. collaborated with Singapore General Hospital for development of blood-based test for ovarian cancer diagnosis. Moreover, fund raising by the market players for the innovation of novel diagnostic procedures also propels the market growth.

 

   Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-ovarian-cancer-diagnostics-market/#ulp-14mlyhjMGhVjZqa3

 

 

Geographically, ovarian cancer diagnostics market is segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Due to increase in the prevalence of ovarian cancer in  U.S. (according to Centres for Disease Control and Prevention 2014, about 21,161 women diagnosed and 14,195 women died of ovarian carcinoma), rise in the healthcare expenditure are propelling the ovarian cancer diagnostics market growth in North America region. Europe exhibiting significant growth in ovarian cancer diagnostics market which is attributed to upsurge in aging women population, highly developed healthcare infrastructure, and increase in the disease prevalence majorly in Estonia, Latvia, Lithuania, and Croatia are expected to fuel the ovarian cancer diagnostics market. ‘Asia Pacific holds significant share owing to rise in aging women population majorly in Japan, China, and India, increase in the healthcare expenditure, and adoption of novel techniques for diagnosis.

 

 

Some of the players in ovarian cancer diagnostics market are AstraZeneca Plc. (U.K.), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Siemens AG (Germany), Roche Holding AG (Switzerland), Myriad Genetics, Inc. (U.S.), Epigenomics AG (Germany), Thermo Fischer Scientific Inc. (U.S.), VolitionRx Ltd. (Singapore), and Abcodia Ltd. (U.K.) to name a few.

 

 

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-ovarian-cancer-diagnostics-market/

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised which follow a holistic approach to solve needs of market research services based on our client needs.

 

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.

 

Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

 

Contact to Precision Business Insights,

 

Kemp House,

 

152 – 160 City Road,

 

London EC1V 2NX

 

Email: sales@precisionbusinessinsights.com

 

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

 

 

Source: http://www.precisionbusinessinsights.com/market-reports/global-ovarian-cancer-diagnostics-market

Global Orthopaedic Devices Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2024

Global Orthopaedic Devices Market :Orthopaedic device is a medical device which is used to replace missing joint or bone or to give support to the damaged bone. The device is fabricated by using titanium alloys and stainless steel for strength and plastic coating acts as artificial cartilage. Internal fixation is a surgery in orthopaedics which involves implementation of implants in order to repair the damaged bone. Most common orthopaedic medical devices are rods, pins, plates and screws which are used for anchoring of fractured bones while they heal.

 

 

Rising geriatric population is major driving factor of the orthopaedic devices market due to they are highly prone to bone and muscle related disorders like osteoarthritis and osteoporosis. According to WHO, by 2050, global population above 60 years have estimated to reach 2Mn, rising prevalence rate of obesity and diabetes, sedentary life style due to poor physical activity, diet styles and growing trend of consumption of alcohol and smoking, innovations osteology field, growing incidence of accidents and injuries related to sports, are expected to fuel the growth of orthopaedic devices market. Increasing cost burden of the surgeries, high cost of implants, lack of skilled professionals, low reimbursement policies are hampering the growth of the orthopaedic devices market.

 

 A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-orthopaedic-devices-market/#ulp-4H8Z4LpNMLEuOnnx

 

Orthopaedic devices market is segmented on basis of application, product, consumables, end users and geographical regions.

 

Based on application, the orthopaedic devices market is segmented

 

  • Cranio Maxillofacial (CMF)
  • Knee
  • Hip
  • Shoulder
  • Elbow
  • Spine
  • Foot and ankle
  • Others

 

 

Based on product, the orthopaedic devices market is segmented

 

  • Spinal devices
  • Joint reconstruction
  • Ortho biologics
  • Arthroscopic devices
  • Trauma fixation devices

 

 

Based on the consumables, the orthopaedic devices market is segmented

 

  • Orthopaedic staples
  • Orthopaedic suture anchors

 

 

Based on the end user, the orthopaedic devices market is segmented

 

  • Hospitals
  • Orthopaedic clinics
  • Medical centres
  • Research centres

 

 To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-orthopaedic-devices-market/#ulp-c654SbFYO64MsOhu

 

 

The presently available pain management treatments are not capable of successfully restoring the body parts due to unavailability of efficient surgical tools which results in huge investments in R&D to introduce new and efficient devices for treatment of pain management. In 2015, According to the Rheumatoid arthritis support network, rheumatoid arthritis (RA) is affecting about 1.3Mn Americans and about 1% of total world population. Manufacturers are focused on huge investments of R&D and innovative product launches. Despite of the restraints, emerging markets in developing countries and introduction of biologics for the treatment of foot and ankle disorders are expected to offer lucrative opportunities for the manufacturers in the market.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-orthopaedic-devices-market/#ulp-14mlyhjMGhVjZqa3

 

 

 

Orthopaedic Devices Market is segmented as North America, Asia-Pacific, Europe, the Middle East & Africa, and Latin America. North America is the leading market owing to rise in demand for the advanced healthcare services due to availability of well-established healthcare infrastructure and favourable reimbursement policies. National Health Interview Survey (NHIS) estimates states that, about 22.7% of adult population in U.S. were diagnosed with the arthritis every year, significantly high prevalence among women is 23.9% and men is 18.6%. Asia Pacific is anticipated to show tremendous growth due to increased sophisticated healthcare infrastructure, and increased medical tourism in emerging nations. China and India have high growth of geriatric population pool across the globe, growing medical tourism, availability of advanced healthcare treatments at a cheaper cost.

 

 

Some of the players in orthopaedic devices market are Medtronic (U.S.), Stryker (U.S.), Zimmer Biomet (U.S.), ConforMIS (U.S.), DJO Global (U.S.), NuVasive (U.S.), Globus Medical (U.S.), MicroPort OrthopaedicsInc(Wright Medical Group) (U.S.) Medacta (Switzerland), Smith & Nephew ( UK) and DePuy Synthes (U.S.)

 

 

                   

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-orthopaedic-devices-market/

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

Source: http://www.precisionbusinessinsights.com/market-reports/global-orthopaedic-devices-market

Global Oral Care Products Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2024

Global Oral Care Products Market :Oral care is necessary to maintain the good health and quality of the life. Oral care products are used to maintain the dental care and oral hygiene. Oral care products include the devices such as toothbrushes and medicated and non-medicated formulations such as toothpaste, mouthwashes, gargles, and tooth powders etc. These products help in the treatment of oral sores, tooth decay, chronic mouth pains, mouth ulcers, and oral, throat cancer among others.

 

 

Increase in the global population, a rise in awareness about the oral hygiene, technological developments in the oral care products such as battery powered toothbrushes, rise in the prevalence of oral diseases and increase the demand for oral care products used are anticipated to fuel the oral care products market over the forecast period. Moreover, change in the food habits leads to dental cavities, increase in the number of companies and novel product innovations, and an upsurge in the marketing & promotional activities expected to fuel the oral care products market. However, product recalls, stringent regulatory policies, lack of awareness about the oral hygiene products in developing countries, a high cost of the products, and lack of favourable reimbursement policies anticipated to restrain the oral care products market growth over the forecast period.

 

  A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-oral-care-products-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Oral care products market is segmented on the basis of product type, application, formulation type, and distribution channel

 

Based on the product type, oral care products market is segmented into the following:

  • Toothpastes
  • Gels
  • Pastes
  • Powders
  • Others
  • Toothbrushes
  • Electrical
  • Manual
  • Battery powered
  • Mouth washes
  • Medicated mouthwashes
  • Non-medicated mouthwashes
  • Gargles
  • Dental prosthesis and cleaning products
  • Others

 

Based on the application, oral care products market is segmented into the following:

  • Dental cavities
  • Tooth decay
  • Tooth loss
  • Periodontal disease
  • Oral ulcers
  • Others

 

Based on the formulation, oral care products market is segmented into the following:

  • Powders
  • Liquids
  • Semi-solids

 

Based on the distribution channel, oral care products market is segmented into the following:

  • Hospital pharmacies
  • Retail pharmacies
  • Online pharmacies
  • Drug Stores
  • Retail Stores
  • Others

 

    To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-oral-care-products-market/#ulp-c654SbFYO64MsOhu

 

Oral care products market is in the flourishing stage with a enormous products available in the market. Increase in the preference for oral hygiene, technological advancements in the oral care products such as electrical toothbrushes, and increase in the prevalence of dental cavities (according to WHO, 60-90% of children and more than 90% of adults are suffering from dental cavities) and periodontal diseases are anticipated to drive the revenue growth of the oral care products market. Acquisitions and mergers, collaborations, product approvals, and product launchings are some strategies followed by the companies for acquiring the oral care products market share. For instance, in April 2014, Oculus Innovative Sciences partnered with More Pharma for the commercialization of mouth and throat infection medicine Microdacyn60 in Mexico. Similarly, in November 2015, Prestige brands acquired the Dentek Holdings, Inc. for the diversification of oral care platform. In addition, in October 2016, Oral Antibacterials Inc. collaborated with Germiphene Corporation for launching UNO gel used to treat dentin hypersensitivity.

 

  Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-oral-care-products-market/#ulp-14mlyhjMGhVjZqa3

 

Geographically, oral care products market is segmented into the North America, Asia Pacific, Europe, Latin America, and Middle East& Africa. Asia Pacific is anticipated to exhibit a significant growth in oral care products market owing to growing general population in India and China. Growing awareness about oral hygiene, and increase in the prevalence of oral diseases such as dental cavities is expected to propel the market growth in the region. In addition, North America plays a key role in the market due to rise in technological advancements in the oral care products, increase in disposable income, presence of skilled dentists and hygienists in U.S Rise in awareness about oral care products expected to fuel the revenue growth of oral care products market in the region. Huge geriatric population, increase in the number of manufacturers, upsurge in the demand for dental products and treatment in Germany, U.K, and Russia etc., and high adoption of novel products are the key factors driving the Europe oral care products market.

 

 

Some of the players in oral care products market are The Procter & Gamble Company (U.S.), Dr. Fresh LLC. (U.S.), Himalaya Drug Company (India), GlaxoSmithKline Plc. (U.K.), Prestige Brands Holdings, Inc. (U.S.), Colgate-Palmolive Company (U.S.), High Ridge Brands Co. (CDR HRB Holdings, Inc.) (U.S.), Oculus Innovative Sciences (U.S.), More Pharma Corporation (Mexico), Oral Antibacterials Inc. (Canada), and Germiphene Corporation (Canada) to name a few.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/global-oral-care-products-market/

 

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com

 

 

 

 

Source: http://www.precisionbusinessinsights.com/market-reports/global-oral-care-products-market

Global Optogenetics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2024

Global Optogenetics Market :Optogenetics is the biological technique in neuroscience used for controlling the cells in the living tissue with the help of a light. Optogenetics is majorly used for monitor and control the activities of neurons in living tissue. Light-sensitive proteins are used as key reagents in the optogenetics. The neuronal control achieved by using optogenetic actuators such as halorhodopsin, channelrhodopsin, and archaerhodopsin. Optical recording of the neuronal activities made with optogenetic sensors for the neurotransmitter, membrane voltage, vesicular release, or calcium. Optogenetics is adopted in the ophthalmology, cardiology, behavioural science, neuroscience, and others.

 

 

Increase in the adoption of optogenetics in the behavioural and neuroscience, technological advancements in optogenetics, growth in ultrafast laser tool technology are the key factors driving the growth of optogenetics market. Moreover, rise in the number of research laboratories adopting optogenetics technology around the globe and development in the genetic engineering research expected to propel the optogenetics market over the forecast period. However, a high cost of the technology, lack of awareness about the optogenetics, and the dearth of skilled professionals for optogenetic research might hamper the optogenetics market over the forecast period.

 

 

 A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-optogenetics-market/#ulp-4H8Z4LpNMLEuOnnx

 

 

Optogenetics market is segmented on the basis of product type, targeting technology, application, and end user

 

Based on the product type, optogenetics market is segmented into the following:

  • Sensors
    • Genetically encoded calcium indicators
    • pH sensors
    • Chloride sensors
    • Neurotransmitter release sensors
    • Voltage-sensitive fluorescent proteins
  • Actuators
    • Halorhodopsin
    • Archaerhodopsin
    • Channelrhodopsin
    • Others
  • Light equipment
    • LEDs
    • Laser
    • Others

 

Based on the technique, optogenetics market is segmented into the following:

  • Viral vectors
  • Transgenic animals
  • Cre-Dependant Expression system

 

Based on the application, optogenetics market is segmented into the following:

  • Neuroscience
  • Behavioural science
  • Cardiovascular diseases
  • Retinal disease treatment
  • Others

 

Based on end user, optogenetics market is segmented into the following:

  • Pharmaceutical & Biopharmaceutical companies
  • Biotechnology companies
  • Academic research institutes

 

   To view TOC of this report is available upon request @

 https://www.precisionbusinessinsights.com/market-reports/global-optogenetics-market/#ulp-c654SbFYO64MsOhu

 

 

Global optogenetics market is growing at a significant CAGR owing to rise in the adoption of optogenetics technology in neuroscience and behavioral science. Innovation of newer technologies for various diseases such as obesity and retinal diseases on optogenetics platform might fuel the optogenetics market growth in near future. For instance, in August 2015, Boehringer Ingelheim and Circuit therapeutic has collaborated to develop the novel medicines for obesity on optogenetics technology platform. Acquisitions and mergers, collaborations, technological advancements, and fund raising are the strategies adopted by the companies for increasing their revenue in optogenetics market. For instance, in November 2015, RetroSense Therapeutics secured US$ 6Mn Series B financing from various organizations for the clinical development of RST-001 for the treatment of Retinitis pigmentosa. Moreover, in November 2016, Bruker targeted on optogenetics market by commercializing NeuraLight 3D an optical module for stimulating and imaging the multiple neurons.

 

 Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/global-optogenetics-market/#ulp-14mlyhjMGhVjZqa3

 

Geographically, optogenetics market is segmented into North America, Latin America, Asia Pacific, Europe, and Middle East & Africa. Increase in the R&D activities in neuroscience and optogenetics and availability of professional researchers in North America are anticipated to create demand for optogenetics research in the region. Moreover, the optogenetics market is developing in the Europe region owing to collaboration between the companies for developing newer technologies on optogenetics platform. However, technological developments in optogenetics market, increase in the applications of optogenetics, and rise in R&D activities in Asia Pacific region plays a key role in optogenetics market growth.

 

 

Some of the players in optogenetics market are Coherent, Inc. (U.S.), Noldus Information technology (Netherlands), Thorlabs, Inc. (U.S.), Bruker (U.S.), Laserglow Technologies (Canada), Regenexbio, Inc. (U.S.), GenSight Biologics S.A. (France), Jackson Laboratory (U.S.), Applied Genetic Technologies Corporation (U.S.), and Circuit Therapeutics, Inc. (U.S.) to name a few.

 

                   

Get access to full summary @

 

https://www.precisionbusinessinsights.com/market-reports/global-optogenetics-market/

 

 

 

 

About Precision Business Insights

 

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

 

Contact to Precision Business Insights,

 

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US): +1-866-598-1553

Website @ https://www.precisionbusinessinsights.com